TNF and inflammatory bowel disease: Conventional IBD treatments are intended to turn off the inflammation in the acute phase of the disease and/or extend remission periods, and these include aminosalicylates, corticosteroids, antibiotics, immunosuppressive agents, and biologics [40], such as therapeutic TNF-α antagonists.